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Magnetic nanoparticles produced using aqueous coprecipitation usually exhibit wide particle size distribution. Synthesis of
small and uniform magnetic nanoparticles has been the subject of extensive research over recent years. Sufficiently small
superparamagnetic iron oxide nanoparticles easily permeate tissues and may enhance the contrast in magnetic resonance imaging.
Furthermore, their unique small size also allows them to migrate into cells and other body compartments. To better control their
synthesis, a chemical coprecipitation protocol was carefully optimised regarding the influence of the injection rate of base and
incubation times.The citrate-stabilised particles were produced with a narrow average size range below 2 nm and excellent stability.
The stability of nanoparticles was monitored by long-term measurement of zeta potentials and relaxivity. Biocompatibility was
tested on the Caki-2 cells with good tolerance. The application of nanoparticles for magnetic resonance imaging (MRI) was then













Magnetic resonance imaging (MRI) is a noninvasive and
powerful medical imaging technique. MRI is based on
nuclear magnetic resonance (NMR), which is widely used
for the study of molecular structures. MR images, whose
intensity reflects local relaxation rates of water protons, can
be used for visual discrimination of different physiological
and pathological tissues [1]. In many cases, native contrast
provides sufficient anatomic and functional discrimination
capability, but for specific tasks, such as characterisation of
perfusion, identification of tumours, or tracking the distribu-
tion of drug carriers, the administration of a suitable poten-
tially functionalisedMRI probe, for example, a contrast agent,




of protons of the surrounding water molecules in
some ratio and, based on the mechanism of the local probe-
water interaction and the local concentration of the probe
particles, they affect the MR image intensity. In principle,
there are two basic types of contrast agent. Probes based on
gadolinium (Gd3+) act as positive 𝑇
1
-contrast agents because
they are paramagnetic complexes that noticeably shorten the
𝑇
1
longitudinal relaxation time and, hence, lead to signal
enhancement [2]. On the contrary, iron oxide magnetic
particles (IOMPs), which are the most common 𝑇
2
-contrast
probes, shorten the transverse relaxation time and typically
result in a lower signal. Of course, relaxivity is dependent on
nanoparticle (NP) size [3], surface modification [4], and the
magnetic field strength used [5]. In some measurement pro-
tocols, superparamagnetic iron oxide nanoparticles (SPIOs)
of sufficiently small size can serve as a positive 𝑇
1
-contrast
probe as well [6].
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) are popular and some products based on these
materials have been approved by the US FDA for clinical
medical use, for example, Sinerem (Guerbert), Clariscan (GE
Healthcare), Endorem (Guebert), Resovist, Abdoscan (GE
Healthcare), and Lumirem (Guebert) [7, 8]. The IOMPs are
notably suitable for imaging of liver, spleen, bone marrow,
and lymph nodes because the cells of reticuloendothe-
lial systems selectively accumulate IOMPs [9]. The IOMP
nanoparticles may exhibit some cytotoxicity via autoxidation
and the Fenton reaction resulting in the oxidation of proteins
and lipids and damage of nucleic acids [10]. The IOMPs have
been found slightly cytotoxic in vitro; however, they have
been shown biocompatible in vivo at low concentrations [11].
Different methods have been developed for the pro-
duction of IOMP NPs [12]. A simple synthetic method
not requiring special conditions is chemical coprecipitation.
This reaction can be performed at 20–90∘C and favourably
realized under inert gas. The final product is obtained within
minutes to a few hours. The size, shape, and composition of
themagneticNPs are dependent on the type of salts used (e.g.,
chlorides, sulfates, and nitrates), the molar ratio of iron ions
in solution, the concentration and properties of the chosen
base (typically NaOH or NH
4
OH), the reaction temperature,
the presence of a detergent, the ionic strength, and the rate
of base addition. A higher mixing rate tends to decrease size
and prevent aggregation. The resulting product also depends
on the arrangement of the reaction, that is, whether the base
is added to the iron ion solution or vice versa. This method
is preferred due to its simplicity and cost effectiveness and
is noted for its high yields. Significant polydispersity of the
synthesised NPs is usually a disadvantage of this method.
However, once the synthetic conditions are optimised and
stabilised, the quality of NPs is fully reproducible as shown
in this work. Sugimoto and Matijević prepared spherical
magnetite by coprecipitation of ferrous ions by potassium
hydroxide in the presence of nitrate [13]. One of the pioneer
works reported by Massart in 1981 described an alkaline
coprecipitation protocol [14]. An aqueous solution of ferrous
and ferric ions in a 2 : 1 stoichiometry wasmixed with ammo-
nia solution giving gelatinous precipitate, which was isolated
and further peptised.The average size of those NPs was about
12 nm. Since that time, many other modifications have been
examined. The coprecipitation of very fine maghemite NPs
using citrate stabilising ions was described by Bee et al. [15].
The synthesis and surface modification of magnetic par-
ticles are limited by several aspects. According to the ther-





a mixture of ferrous and ferric ions is expected within a pH
range of 9–14 and under nonoxidising atmosphere [16]. High
surface energy of particles leads to aggregation; chemical
reactivity (mainly oxidation) may cause the loss of magnetic
properties and dispersibility in solution. Therefore, the mag-
netic core can be protected by a functional shell of various
properties and chemistries allowing chemical steric stabilisa-
tion and bioconjugation. Protective shells include hydrophilic
nature macromolecular polymers (agarose [17], dextran [18],
chitosan [19], and gelatine [20]), polymers (polyethylene
glycol [21], polyethyleneimine, polyvinyl alcohol [22], and
polystyrene [23]), and self-assembled (mono)layers (silica
and phospholipids [24]). The van der Waals interactions
in this case become negligible. Electrostatic repulsion helps
stabilise the dispersion of NPs in solution, which is usually
given by electric charges introduced at the NPs’ surface
coming from adsorption of charged ions or ionisation of
hydroxyl groups at the IOMPs. The electric surface charge
appearing on the surface is affected by ionic strength and pH.
This behaviour is remarkable for coating species that are able
to gain or lose protons (citric acid/citrate, orthophosphoric
acid/phosphate, oleic acid, etc.) [15, 25]. Another widely used
technique is controllable encapsulation of NPs in a silica
shell. The silica layer helps protect the magnetic core against
oxidation and sintering and, thus, prevents the aggregation
of NPs [26]. The pH stability of silica and silanised NPs is
given by the isoelectric point of silica close to pH2 [27]. For in
vivo applications, the stabilisers should be biocompatible and
biodegradable. They can be incorporated to the NPs during
their synthesis or in a postsynthesis manner.
The chemical coprecipitation of citrate-stabilised NPs is
described here. NP size was analysed by atomic force micros-
copy (AFM) and dynamic light scattering (DLS). The zeta
potential wasmonitored over a long period and the properties
of the NPs important for MRI were tested in a 9.4 T NMR
system.
2. Experimental Section
2.1. Materials. Acrylamide, ammonium persulfate, ferrous




from Sigma Aldrich (St. Louis, MO, USA). Isotonic saline
solution 0.9% was from B. Braun (Melsungen, Germany).
Ammonium, acetone, boric acid, and hydrochloric acid were
from Penta (Prague, Czech Republic). The human Caucasian
kidney carcinoma Caki-2 cell line (ATCC HTB-47) was
obtained from the European Collection of Cell Cultures.
Dulbecco’s modified Eagle medium (DMEM), supplemented
with fetal bovine serum, streptomycin, nonessential amino
acids, L-glutamine, and sodium pyruvate, was purchased
from Invitrogen (Gibco, Carlsbad, CA, USA).
2.2. Preparation of Iron Oxide Nanoparticles. The synthesis
was carried out in water under ambient conditions. Ferrous
and ferric chlorides were dissolved in 2MHCl in molar ratio
2 : 1 and final concentration of 250mM. Citrate ions were
used as nucleation stabilisers. The reactor was filled with
inert argon atmosphere and the NPs were slowly precipitated




O (5.5M) under vigorous mixing.
The critical point of the synthesis is the core formation of
the IOMPs and consequent crystal growth; therefore, the
reaction conditions, including time and rate of base addition,
were carefully optimised.The slow formation of nanoparticle
seeds was followed by a faster formation of cores and a
slow formation of shells stabilised by citrate ions for the
whole time. The brownish-red product was precipitated with
acetone, centrifuged for 5minutes at 4,000 rpm, and the pellet
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dispersed in argon-bubbled water. These steps were repeated
twice to reliably wash the NPs. After the last dispersion
in water, the residues of acetone were evaporated under
vacuum.The final product was sterilised by filtration through
a 0.22𝜇mfilter.TheNPs can be stored either in the lyophilised
form or in an aqueous solution for a long time.
2.3. Characterisation Using AFM. Atomic force microscopy
(AFM) images were captured on Ntegra Vita/Solaris (NT-
MDT, Russia) using the semicontact mode. The NPs were
diluted in deionised water and 20 𝜇L of this dispersion was
put on freshly cleaved mica and the water evaporated. As a
probe, silicon cantilevers (AppNano, USA) with resonance
frequency of 𝑓
0
= 300 kHz, spring constant of 𝑘 = 37N/m
and a tip radius less than 10 nm were used. The scan rate was
set at 1 Hz.The images were flattened and processed for better
quality and the particle sizeswere determined from the height
scans by means of Nova software.
2.4. Size Distribution. The particle size distribution of NPs
was obtained by dynamic light scattering using Zetasizer
Nano ZS (Malvern Instruments, UK). In the backscattering
mode (angle of detection 173∘, measuring position 1mm
from the wall of the cuvette), the instrument detects the
time development of the intensity of light scattered by
moving particles in the sample after irradiation with a He-
Ne laser beam (5mW, 633 nm). The data obtained undergo
autocorrelation analysis and are subsequently evaluated using
the methods of statistical data analysis (both Cumulant
analysis and CONTIN algorithm) to obtain the particle
size distributions. More details about these mathematical
concepts can be found elsewhere [28].The data shown in this
work represent the mean distributions calculated from four
independent repetitions. The measurement was carried out
at laboratory temperature.
2.5. Zeta Potential. The zeta potential of the samples was
determined using the method of electrophoretic light scat-
tering using Zetasizer Nano ZS instrument (Malvern Instru-
ments, UK). The instrument detects the Doppler shift
between the laser beam (5mW, 633 nm) passing through
the cuvette with the sample and the reference beam passing
outside the cuvette. The data are evaluated using phase
analysis light scattering. A zeta dip cell was used to introduce
an electric field into the sample (applied voltage 4.96±0.05V).
All presented zeta potentials are reported as the mean value
of five independentmeasurements at laboratory temperature.
2.6. Isotachophoretic Separation. The isotachophoretic (ITP)
separation was used for concentration and size-sorting of
small-sized NPs. The vertical homemade apparatus was
described elsewhere [29]. The movement of raw negatively
charged IOMPs was established by a system of two buffers:
the leading electrolyte (LEL; 100mM Tris, pH 8.38) and the





The separation channel of the ITP device was filled with 1%
agarose gel prepared in LEL. The mixture of IOMPs (140 𝜇L;
concentration 45mg⋅mL−1), 50% glycerol (40 𝜇L), and 10x
concentrated TEL (20𝜇L) was loaded on agarose gel.The ITP
was performed in constant voltage mode at 50V. The higher
concentration of IOMPs resulted in a total running time of
80min. The final band (width of 1 cm) was cut to 4 pieces
and IOMPs were transferred from the gel to 20 𝜇L of Tris
buffer and PAGE electrophoresis of those separated IOMPs
was performed in accordance with supporting information
for [29].
2.7. Cytotoxicity Assay. The cell viability was tested by the
MTS method. Caki-2 cells were harvested in 24-well plate
at an initial density of 50 × 103 cells per well. The cell line
wasmaintained in 500 𝜇L (per well) of DMEM supplemented
with fetal bovine serum (20%), 100𝜇g⋅mL−1 streptomycin,
0.1mM nonessential amino acids, 2mM L-glutamine, and
1mM sodium pyruvate.The incubation conditions were 37∘C
with 5%CO
2
. Subsequently, after 24 hours of incubation, NPs
in four different concentrations (50, 20, and 5𝜇g⋅mL−1, with
0 𝜇g⋅mL−1 as a negative control) were added to the cells and
the plates were incubated for 6, 24, 48, and 72 h. To each
well, 50 𝜇L of 5mg⋅mL−1 MTS solution in PBS was added
at 6, 24, 48, and 72 h after NP addition and the plates were
incubated for 1 h at 37∘C. Absorbance wasmeasured using the
Multi-Detection Microplate Reader (BioTek, Winooski, VT,
USA) at a wavelength of 490 nm. Cell viability was calculated
fromOD
490
value of the experimental group (in triplicate) by
subtracting that of the blank group.
2.8. Relaxivity and MRI Studies. All experiments were per-
formed using a 9.4 T NMR system (Bruker-BioSpec 94/
30USR, Ettlingen, Germany). The series with different con-





) in saline solutions containing 1.5% agar gel
were prepared for relaxivity MRI phantom studies. Agar
gel was preferred to a simple aqueous solution in order to
avoid inhomogeneity due to possible sedimentation and a





were acquired using the Rapid Acquisition with Relaxation
Enhancement (RARE) pulse sequence [30]. The parameters
for 𝑇
1
quantification were TR = 50, 100, 250, 500, 1000,
2000, 3000, 5000, 10000, and 15000ms; TE = 10ms; for 𝑇
2
quantification were TR = 15,000ms; TE = 10, 30, 50, 70, 90,
110, 130, and 150ms, where TR is the repetition time and TE
the effective echo time. Slice thickness (SL) for all acquisitions
was 1mm, matrix 128 × 128, field of view (FOV) 6 × 4 cm,




were calculated for each sample inmanually drawn regions of
interest (ROIs) using the Image Sequence Analysis tool (Par-




relaxivities were calculated as the proportionality constants





concentration (in IOMPNPs).The sampleswere
measured at room temperature and at 37.7∘C.
3. Results and Discussion
3.1. Characterisation of Citrate-Stabilised IOMPs. Using the
chemical coprecipitation technique, well-dispersible IOMPs
4 Journal of Nanomaterials
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Figure 1: Demonstration of very fast reconstitution of dried IOMP nanoparticles in water. No special conditions (sonication, detergents, etc.)
are needed. Only adding IOMPs in water and one flip of the vial is sufficient for stable dispersion in a few seconds.





is thermodynamically unstable and it is highly sensitive to




). For smaller NPs a
higher rate of oxidation of magnetite to maghemite should
be expected.Therefore, the coprecipitation method is usually
limited by a broad distribution of NP sizes. Here, the
reaction conditions were carefully optimised to overcome
this disadvantage. A slower reaction during the preparation
results in very fine NPs that are highly stable in water for long
periods. Furthermore, no special conditions were needed
to form stable brown suspensions in water. Dispersion of
lyophilised nanoparticles was very fast, in the order of few
seconds (Figure 1).
Particle size was determined by atomic force microscopy.
The average size derived from the height scan was below
2 nm. The distribution profile of sizes from the AFM height
scan is shown in Figure 2(a). A section of the AFM scan is
included in the inset. The results from the AFM correspond
to the distribution acquired from DLS (Figure 2(b)). The
hydrodynamic diameter distribution of the IOMPs was of
3.6 nm and volume ratio of 16.9%.The hydrodynamic diame-
ter by DLS is slightly larger than that determined by AFM, as
expected.TheDLS and AFM analyses conducted on standard
polystyrene NPs have been compared previously and small
differences between both methods and nominal values were
deduced [31]. A similar study has been performed elsewhere
and it was observed that DLSwas limited for accurate particle
sizing and mostly DLS provides higher values [32]. Figure 2
indicates that the optimised coprecipitation method effec-
tively produces a well-dispersed and narrower distribution of
particle diameters. The high stability of IOMP NPs is given
by their very low electrostatic potential. As can be seen by the
measurement of zeta potential, the citrate-stabilised IOMP
NPs are very stable (Table 1). The zeta potential of NPs was
constant at around −39mV for long-term storage (over 16
months).
Table 1: Stability of zeta potential of IOMPs nanoparticles during
two months.
Time 𝜁 Potential [mV] SD [mV]
0 days −39.5 1.0
4 days −39.1 3.0
9 days −37.8 0.9
11 days −39.3 2.5
14 days −39.2 1.6
60 days −39.2 1.7
In addition, there was neither macroscopic nor micro-
scopic significant change in behaviour and stability of NPs
after 16-month storage in dispersion at room temperature,
even at higher concentrations. For in vivo applications,
the NPs have to be sterile. Autoclaving was performed for
20 minutes at 121∘C without any impact on the IOMPs’
properties. A combination of acetone precipitation during the
washing process and filtration through a 0.22𝜇m filter is also
sufficient and has no effect on the stability of NPs.
3.2. Isotachophoretic Separation. For meaningful MR imag-
ing, it is necessary to use small as well as uniformly magnetic
NPs with well-defined sizes. Different separation techniques
are currently available for size- and shape-selective purifi-
cation, such as size exclusion chromatography (SEC) [33],
density gradient centrifugation [34], magnetic separation
[35], and electrophoretic methods [36]. Relatively low capac-
ity and dilution of samples are the disadvantages of the
SEC method. The centrifugation and magnetic separation
methods are limited by the stability of dispersion. The
high stability of our NPs allows neither centrifugation nor
magnetic separation. The isotachophoresis was chosen here
as the efficient technique for the separation of highly stable

































Figure 2: AFM (a) and DLS (b) size profiles. The histogram of IOMP sizes derived from height profile of AFM scan on square 2 × 4𝜇m.
The section of AFM scan (inset) represents the 2 × 2 𝜇m area. The DLS hydrodynamic size distribution by volume shows narrower peak
corresponding to AFM height profile.
(a) (b)
Figure 3: Isotachophoretic size sorting and preconcentration (a) with electrophoretic characterisation of IOMP NPs (b). The ITP cell was
filled with agarose gel (a). The potential of electrodes and the sample movement during preconcentration is depicted. Individual zones (A, B,
C, and D) of the cut concentrated sample were electrophoretically separated on the PAGE and nonconcentrated IOMPs sample was used as
control (Z). The diffusion of concentrated IOMPs in the gel is very fast as can be seen on unfocused bars.
NPs. The PAGE electrophoresis (Figure 3) of separated frac-
tions revealed narrower size distribution and quality of the
developed synthetic process.The distribution and intensity of
bars correspond to the results achieved by DLS and AFM. In
the electrophoregram, the “B” band represents the major size
component contained in the original sample. Besides the size-
sorting effect, the concentration of various individual sizes
is a valuable advantage of isotachophoresis. In this case, the
sample was 10x more concentrated than the nonseparated
sample applied on the column. In addition, there was no
significant instability of NPs during electrophoretic move-
ments. The NPs were free of aggregates and retained good
dispersibility.
3.3. Cytotoxicity Assay. To evaluate the potential cytotoxicity
of NPs, a cell viability test (MTS assay) was performed.
The MTS assay is a colorimetric method based on the
reduction of MTS tetrazolium compound by viable cells.
The product of the reaction is a purple-coloured formazan
soluble in the DMEM media. The conversion is performed
due to NAD(P)H-dependent dehydrogenase enzymes in
metabolically active cells. The formazan dye produced by
viable cells is subsequently quantified by measuring the
absorbance at 490 nm (Figure 4). It was observed that the
highest concentration of NPs (50𝜇g⋅mL−1) caused a shock to
cells during first six hours after NP addition. However, after
this initial shock, at the following time steps, the cells grew
in the same manner as cells with lower NP loadings or as the
negative control.These data show that even the highest tested
NP concentration did not exhibit toxicity in the Caki-2 cell.
3.4. Relaxivity and MRI Studies. For the IOMPs











s−1 at 37.7∘C. The main reason for the low
values was most probably the high magnetic field applied
here (9.4 T), compared to the magnetic field usually used
in the most publications (1.5 and 3 T). The relaxivities




















Figure 4: Cytotoxicity of IOMPNPs on Caki-2 cells.Three different
concentrations of IOMPs were added to the Caki-2 cells and
incubated for 6, 24, 48, and 72 hours. The cytotoxicity has been
compared with the negative control with 0 concentrations of NPs.
At 24 hours, the toxic shock by adding of 50𝜇g⋅mL−1 can be seen. A
couple of hours later, proliferative behaviour was influenced even by





















































IOMPs. The concentration gradient of NPs was prepared in saline
containing 1.5% agarose.The relaxation timesweremeasured at 20∘C












s−1 at 37.7∘C, respectively. All data,
including the relaxivities, are shown in Figure 5. These
relaxivity values correspond to values claimed on commercial
NPs with a nominal diameter of 20 nm [37]. In their study,
Najafian et al. deduced that there is an influence of the phys-
icochemical properties of the superparamagnetic NPs
0 0.083 0.167 0.291 0.415 0.620
Figure 6: Phantom images of concentration gradient of IOMPs.
𝑇
2
weighted RARE sequence measured in saline containing 1.5%
agarose: TR 15 s; TE 110ms (negative contrast).The concentration of
IOMPs is indicated in mM. Identical phantoms are shown in black
and white (upper row) and pseudocolour (lower row) scale.
attributable to different surface modifications. The surface
charge seems to affect relaxivitymore than the hydrodynamic




ratio, which was ∼47 for our NPs at 37.7∘C




The MRI images of the phantom with different concen-
trations of IOMPs are shown in Figure 6. The relaxivities
of IOMPs were regularly measured within one month and
showedhigh stability andno aggregation in a strongmagnetic
field (data not shown). The data confirm that our ultra-
small NPs can serve as alternative 𝑇
2
MRI contrast agents.
Due to their very small size and good hydrophilicity, the
produced NPs should easily permeate tissues and achieve
more widespread tissue distribution in a short time.
4. Conclusions
Well-dispersible, ultra-small, and hydrophilic iron oxide
nanoparticles were synthesised by a chemical coprecipitation
method. A citrate shell stabilises the dispersion and protects
NPs against aggregation and sedimentation. The procedure
was optimised for the production of NPs with a narrow size
distribution, which was confirmed by AFM and DLS mea-
surements. High stability was confirmed by monitoring of
zeta potential, which detected no change over severalmonths.
Isotachophoresis (ITP)was used for preconcentration ofNPs.
It was clearly shown that ITP could also be applied for
purification and sorting of IOMPs. In vitro cytotoxicity MTS
assay confirmed biocompatibility of the prepared NPs. The











AFM: Atomic force microscopy
DLS: Dynamic light scattering
IOMPs: Iron oxide magnetic particles
ITP: Isotachophoresis
LEL: Leading electrolyte
MRI: Magnetic resonance imaging
NMR: Nuclear magnetic resonance
NPs: Nanoparticles
SPIOs: Superparamagnetic iron oxide nanoparticles
TEL: Terminating electrolyte
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TE: Effective echo time
TR: Repetition time.
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